SOW
VYGR icon

State of Wyoming’s Voyager Therapeutics VYGR Stock Holding History

State of Wyoming’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,904
Closed -$50.5K – 1861
2024
Q4 		$50.5K Sell
8,904
-5,191
-37% -$33.5K 0.01% 1422
2024
Q3 		$82.5K Buy
+14,095
New +$102K 0.01% 1254
2024
Q2 		– Sell
-30,948
Closed -$288K – 1890
2024
Q1 		$288K Buy
30,948
+4,357
+16% +$36.8K 0.05% 374
2023
Q4 		$224K Buy
26,591
+6,077
+30% +$44.1K 0.04% 479
2023
Q3 		$159K Sell
20,514
-13,559
-40% -$124K 0.03% 614
2023
Q2 		$390K Buy
+34,073
New +$352K 0.11% 108
2023
Q1 		– Sell
-4,401
Closed -$26.8K – 1795
2022
Q4 		$26.8K Buy
4,401
+649
+17% +$3.69K 0.01% 1284
2022
Q3 		$22K Buy
+3,752
New +$24K 0.01% 1301

Other funds holding VYGR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State of Wyoming's VYGR Position: Q1 2025 in Review

State of Wyoming sold out of Voyager Therapeutics (VYGR) in Q1 2025, closing a stake of 8,904 shares — an estimated $50.5K sold.

State of Wyoming first reported a position in VYGR in Q3 2022 and held it in 8 quarters. The position peaked at $390K in Q2 2023. 116 funds tracked by Wall St. Rank hold VYGR as of Q1 2025.

  • State of Wyoming reported no remaining Voyager Therapeutics position as of Q1 2025 after selling out during the quarter.
  • State of Wyoming sold 8,904 Voyager Therapeutics shares in Q1 2025, an estimated $50.5K.
  • State of Wyoming first reported a position in Voyager Therapeutics in Q3 2022 and held it in 8 quarters.
  • State of Wyoming's Voyager Therapeutics position peaked at $390K in Q2 2023.
  • 116 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2025.

Based on State of Wyoming's 13F filing for Q1 2025, filed 14 May 2025.